文献速递心外重症与机械循环支持

左心室辅助装置支持患者的24小时血压和心率变异性降低

Twenty-four-hour blood pressure and heart rate variability are reduced in patients on left ventricular assist device support.
PubMed 文献 · J Heart Lung Transplant · 2022-02-27

前瞻性记录HeartMate II左心室辅助装置(LVAD)支持患者的诊室及24小时动态血压和心率数据,并与射血分数≤30%的心衰患者及无心血管疾病史的对照者比较。结果显示LVAD患者正常夜间血压下降和心率下降均较少见,而夜间血压反升更常见;超过三分之一LVAD患者存在持续性高血压,四分之一有白大衣高血压。

要点

  • LVAD患者正常夜间血压下降(10%)少于心衰患者(28%)和对照者(62%),夜间血压反升(24%)多于心衰(16%)和对照者(8%),p < 0.001。
  • LVAD患者生理性心率下降(14%)少于心衰(16%)和对照者(59%),p < 0.001。
  • 36%的LVAD患者24小时内存在持续性高血压,25%有白大衣高血压。

核心结论

  • 晚期心衰接受LVAD治疗不能恢复血压和心率的生理性昼夜变异;超过三分之一的LVAD患者血压未得到充分控制,四分之一表现为白大衣高血压。
  • 未来需进一步研究以确认这些发现并探讨其预后和管理意义。

研究设计与样本

  • 前瞻性记录接受HeartMate II LVAD支持患者的诊室及24小时动态血压和心率数据,并与射血分数≤30%的心衰患者及无心血管疾病史的对照者比较。
  • 共纳入29例LVAD患者(年龄59 ± 15岁,76%男性,38%缺血性病因)、25例心衰患者(年龄64 ± 13岁,84%男性,32%缺血性病因)和26例对照者(年龄56 ± 9岁,62%男性)。

主要发现

  • 正常夜间血压下降在LVAD患者中占10%,少于心衰患者的28%和对照者的62%;夜间血压反升在LVAD患者中占24%,多于心衰患者的16%和对照者的8%,p < 0.001(所有比较)。
  • 生理性心率下降在LVAD患者中占14%,少于心衰患者的16%和对照者的59%,p < 0.001(所有比较)。
  • 在LVAD患者中,36%在24小时内存在持续性高血压,25%有白大衣高血压。

关键数值与推荐

  • 生理性夜间血压和心率下降定义为较日间值下降≥10%。
  • 正常夜间血压下降:LVAD患者10% vs 心衰患者28% vs 对照者62%;夜间血压反升:LVAD患者24% vs 心衰患者16% vs 对照者8%;生理性心率下降:LVAD患者14% vs 心衰患者16% vs 对照者59%;以上比较均p < 0.001。
  • LVAD患者中持续性高血压占36%,白大衣高血压占25%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 未来需进一步研究以确认这些发现并探讨其预后和管理意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Limited data exist on the circadian blood pressure (BP) and heart rate (HR) variations that occur in heart failure (HF) patients on left ventricular assist device (LVAD) support. METHODS: We prospectively recorded clinic and 24-hour ambulatory BP and HR data in patients on HeartMate II LVAD support. Results were compared to HF patients with ejection fraction ≤30% and controls with no history of cardiovascular disease. Physiologic nocturnal BP and HR dipping was defined as a ≥10% decline compared to daytime values. RESULT: Twenty-nine LVAD patients (age 59 ± 15 years, 76% male, 38% ischemic etiology), 25 HF patients (age 64 ± 13 years, 84% male, 32% ischemic etiology) and 26 controls (age 56 ± 9 years, 62% male) were studied. Normal nocturnal BP dipping was less frequent in LVAD patients (10%) than in HF patients (28%) and controls (62%) and reversed BP dipping (BP increase at night) was more common in LVAD patients (24%), compared to HF (16%) and controls (8%), (p < 0.001, for all comparisons). Physiologic HR reduction was less frequent in LVAD patients (14%), compared to HF (16%) and controls (59%) (p < 0.001, for all comparisons). Among LVAD patients, 36% exhibited sustained hypertension over the 24-hours and 25% had white-coat hypertension. CONCLUSIONS: Treatment of advanced HF with an LVAD does not restore physiologic circadian variability of BP and HR; additionally, BP was not adequately controlled in more than a third of LVAD patients, and a quarter of them exhibited white-coat hypertension. Future studies are warranted to confirm these findings and investigate prognostic and management implications in this population.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Castagna F, McDonnell BJ, Mondellini GM, et al. Twenty-four-hour blood pressure and heart rate variability are reduced in patients on left ventricular assist device support. J Heart Lung Transplant. 2022. PMID: 35422348. doi:10.1016/j.healun.2022.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。